UniProt ID | HMGN5_HUMAN | |
---|---|---|
UniProt AC | P82970 | |
Protein Name | High mobility group nucleosome-binding domain-containing protein 5 | |
Gene Name | HMGN5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 282 | |
Subcellular Localization | Nucleus . Associates with nucleosomes in euchromatin and is largely excluded from constitutive heterochromatin.. | |
Protein Description | Preferentially binds to euchromatin and modulates cellular transcription by counteracting linker histone-mediated chromatin compaction.. | |
Protein Sequence | MPKRKAAGQGDMRQEPKRRSARLSAMLVPVTPEVKPKRTSSSRKMKTKSDMMEENIDTSAQAVAETKQEAVVEEDYNENAKNGEAKITEAPASEKEIVEVKEENIEDATEKGGEKKEAVAAEVKNEEEDQKEDEEDQNEEKGEAGKEDKDEKGEEDGKEDKNGNEKGEDAKEKEDGKKGEDGKGNGEDGKEKGEDEKEEEDRKETGDGKENEDGKEKGDKKEGKDVKVKEDEKEREDGKEDEGGNEEEAGKEKEDLKEEEEGKEEDEIKEDDGKKEEPQSIV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MPKRKAAGQGDM ---CCCCCCCCCCCC | 49.03 | 7668519 | |
5 | Methylation | ---MPKRKAAGQGDM ---CCCCCCCCCCCC | 49.03 | 7668519 | |
20 | Phosphorylation | RQEPKRRSARLSAML CCCHHHHHHHHHHHE | 23.05 | 25159151 | |
24 | Phosphorylation | KRRSARLSAMLVPVT HHHHHHHHHHEECCC | 13.18 | 25159151 | |
25 | Ubiquitination | RRSARLSAMLVPVTP HHHHHHHHHEECCCC | 10.42 | 24816145 | |
26 | Sulfoxidation | RSARLSAMLVPVTPE HHHHHHHHEECCCCC | 3.31 | 21406390 | |
31 | Phosphorylation | SAMLVPVTPEVKPKR HHHEECCCCCCCCCC | 13.99 | 29255136 | |
35 | Acetylation | VPVTPEVKPKRTSSS ECCCCCCCCCCCCCC | 43.06 | 23954790 | |
35 | Ubiquitination | VPVTPEVKPKRTSSS ECCCCCCCCCCCCCC | 43.06 | 24816145 | |
41 | Phosphorylation | VKPKRTSSSRKMKTK CCCCCCCCCCCCCCH | 33.28 | - | |
42 | Phosphorylation | KPKRTSSSRKMKTKS CCCCCCCCCCCCCHH | 35.37 | - | |
47 | Phosphorylation | SSSRKMKTKSDMMEE CCCCCCCCHHHHHHH | 32.08 | 27690223 | |
48 | Acetylation | SSRKMKTKSDMMEEN CCCCCCCHHHHHHHH | 38.65 | 26822725 | |
48 | Ubiquitination | SSRKMKTKSDMMEEN CCCCCCCHHHHHHHH | 38.65 | - | |
49 | Phosphorylation | SRKMKTKSDMMEENI CCCCCCHHHHHHHHH | 35.65 | 29214152 | |
51 | Sulfoxidation | KMKTKSDMMEENIDT CCCCHHHHHHHHHCH | 4.74 | 21406390 | |
58 | Phosphorylation | MMEENIDTSAQAVAE HHHHHHCHHHHHHHH | 23.36 | 27690223 | |
59 | Phosphorylation | MEENIDTSAQAVAET HHHHHCHHHHHHHHH | 18.03 | 28674419 | |
67 | Sumoylation | AQAVAETKQEAVVEE HHHHHHHHHHHHHHH | 37.33 | 28112733 | |
67 | Sumoylation | AQAVAETKQEAVVEE HHHHHHHHHHHHHHH | 37.33 | - | |
76 | Phosphorylation | EAVVEEDYNENAKNG HHHHHHHHHHHCCCC | 27.88 | 29978859 | |
81 | Acetylation | EDYNENAKNGEAKIT HHHHHHCCCCCCEEC | 76.65 | 26051181 | |
88 | Phosphorylation | KNGEAKITEAPASEK CCCCCEECCCCCCHH | 25.95 | 30266825 | |
93 | Phosphorylation | KITEAPASEKEIVEV EECCCCCCHHHHEEE | 48.41 | 30266825 | |
95 | Ubiquitination | TEAPASEKEIVEVKE CCCCCCHHHHEEEHH | 50.69 | 29967540 | |
95 | Acetylation | TEAPASEKEIVEVKE CCCCCCHHHHEEEHH | 50.69 | 23954790 | |
101 | Ubiquitination | EKEIVEVKEENIEDA HHHHEEEHHHHHHHH | 45.89 | 32015554 | |
101 | Sumoylation | EKEIVEVKEENIEDA HHHHEEEHHHHHHHH | 45.89 | 25114211 | |
101 | Sumoylation | EKEIVEVKEENIEDA HHHHEEEHHHHHHHH | 45.89 | - | |
101 | Acetylation | EKEIVEVKEENIEDA HHHHEEEHHHHHHHH | 45.89 | 26051181 | |
111 | Acetylation | NIEDATEKGGEKKEA HHHHHHHHCCHHHHH | 68.79 | 23954790 | |
124 | Sumoylation | EAVAAEVKNEEEDQK HHHHHHHCCHHHHHH | 50.58 | 25218447 | |
124 | Sumoylation | EAVAAEVKNEEEDQK HHHHHHHCCHHHHHH | 50.58 | - | |
149 | Ubiquitination | GEAGKEDKDEKGEED CCCCCCCCCCCCCCC | 69.73 | 29967540 | |
152 | Ubiquitination | GKEDKDEKGEEDGKE CCCCCCCCCCCCCCC | 80.09 | 29967540 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HMGN5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HMGN5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of HMGN5_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-24 AND THR-31,AND MASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-76, AND MASSSPECTROMETRY. |